Grant: Discovery Grants Program - Individual
University of Victoria
$43,000.00
Microfluidics Manufacturing of Polymeric Nanomedicines: Addressing Challenges and Developing Technologies
FY 2024-25
Summary
The treatment of disease is a pressing challenge that touches all Canadians. Although the design and discovery of new therapeutic molecules will continue to play a role in treating chronic conditions, a vital key to the future of disease treatment is making existing drugs safer and more specific. In targeted drug delivery, drugs are formulated using antibodies or nanoparticles to enable targeting to specific regions of the body (e.g. cancerous tumors), thus increasing efficacy and decreasing side effects. Polymer nanoparticles are probably the most widely studied drug delivery systems due to their stability and extensive variability of properties (e.g. viscosity, hydrophobicity, biodegradability). Along with drugs, polymers can also encapsulate various functional nanoparticles, including gold nanoparticles (GNPs), opening up numerous routes to nanomedicine-based therapies. In this proposal, we leverage our established toolbox for the discovery and optimization of new polymer-based nanomedicines using two-phase microfluidics, in order to address specific identified challenges and to develop new technologies. For example, we will address the issue of burst release of encapsulated drugs by establishing manufacturing guidelines based on chemical and processing formulation parameters for the suppression of burst release. In addition, we will combine microfluidic size control of polymer nanoparticles with ligand functionalization to determine the relative roles of size and receptor targeting in nanoparticle-cell interactions. This work will also develop self-assembly routes to new and morphologically diverse plasmonic GNP-based assemblies for photothermal therapy applications, along with establishing the effects and benefits of polymer encapsulation on GNP-mediated radiotherapy.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05972
Name nom
Moffitt, Matthew
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
43000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
2000
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials science and technology
Research subject fr
Science et technologie des matériaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Microfluidics Manufacturing of Polymeric Nanomedicines: Addressing Challenges and Developing Technologies
Keywords
block copolymers; gold nanoparticles; microfluidics; self-assembly; colloids; surfaces; nanomaterials; nanomedicine; drug delivery; theranostics
Application summary
The treatment of disease is a pressing challenge that touches all Canadians. Although the design and discovery of new therapeutic molecules will continue to play a role in treating chronic conditions, a vital key to the future of disease treatment is making existing drugs safer and more specific. In targeted drug delivery, drugs are formulated using antibodies or nanoparticles to enable targeting to specific regions of the body (e.g. cancerous tumors), thus increasing efficacy and decreasing side effects. Polymer nanoparticles are probably the most widely studied drug delivery systems due to their stability and extensive variability of properties (e.g. viscosity, hydrophobicity, biodegradability). Along with drugs, polymers can also encapsulate various functional nanoparticles, including gold nanoparticles (GNPs), opening up numerous routes to nanomedicine-based therapies. In this proposal, we leverage our established toolbox for the discovery and optimization of new polymer-based nanomedicines using two-phase microfluidics, in order to address specific identified challenges and to develop new technologies. For example, we will address the issue of burst release of encapsulated drugs by establishing manufacturing guidelines based on chemical and processing formulation parameters for the suppression of burst release. In addition, we will combine microfluidic size control of polymer nanoparticles with ligand functionalization to determine the relative roles of size and receptor targeting in nanoparticle-cell interactions. This work will also develop self-assembly routes to new and morphologically diverse plasmonic GNP-based assemblies for photothermal therapy applications, along with establishing the effects and benefits of polymer encapsulation on GNP-mediated radiotherapy.